
MDB · Nasdaq
The supplied consensus is Buy across 27 analysts, with a mean price target of $400; low and high targets are not provided, so the target spread and its endpoints cannot be measured. Other cited aggregators show materially different averages, including $355.59 from ChartMill, $394.68 from StockAnalysis, $412.83 from TipRanks, and $364.70 from Zacks, with Zacks reporting a $180 to $430 range. The most bullish identifiable published target is Zacks’ $430 high, while Baird is least bullish at $260 and Neutral. No rating revisions during this reported week are supplied. The substantive disagreement is valuation: revenue growth supports upside, but continuing losses and sharply different targets constrain conviction.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Mizuho | — | $325 | -14.8% | Mar 23, 2026 | Open the report this row came from |